Tendon injuries account for a considerable share of musculoskeletal pathologies as it is estimated that over 30 million human tendon-related procedures are taking place annually worldwide. Up to now, the most used tendon therapeutic strategies are based on application of autografts and allografts, presenting several disadvantages as they require a second surgical procedure that can lead to infection and chronic pain in the harvest site, as well as donor site morbidity. These strategies have poor clinical outcomes, given that tendon tissue does not fully recover its functionality, leading to high re-injury rates, pain and reduced quality of life. Tissue engineering strategies, stem cell based therapies, nanomedicine and molecular based therapies are being increasingly studied in order to create alternative, successful and cost effective treatments for these disorders.
The Achilles project is led by 3Bs Research Group from University of Minho (UMinho). UMinho partners with internationally leading research institutions: the Experimental Trauma Surgery, Department of Trauma Surgery from University Hospital Regensburg in Germany (UHREG), the Regenerative, Modular & Developmental Engineering Laboratory (REMODEL) from National University of Ireland Galway in Ireland (NUI GALWAY ), the Department of Musculoskeletal Regeneration, Orthopaedic Hospital König- Ludwig-Haus, University of Würzburg (JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG) (JMU), and the University College Dublin, National University of Ireland, Dublin (UCD). In addition, in the scope of this project, UMinho will collaborate with the Rehabilitation Medicine Research Center from Mayo Clinic in the USA (MAYO).